title: Response to "calcium supplements increase risk of myocardial infarction".
authors.affiliation: University of Western Australia School of Medicine and Pharmacology, Sir Charles Gairdner Hospital Unit, Perth, Australia; Department of Endocrinology and Diabetes, Sir Charles Gairdner Hospital, Perth, Australia.
authors.forename: Joshua R
authors.initials: JR
authors.lastname: Lewis
authors.forename: Simone
authors.initials: S
authors.lastname: Radavelli-Bagatini
authors.forename: Lars
authors.initials: L
authors.lastname: Rejnmark
authors.forename: Jian Sheng
authors.initials: JS
authors.lastname: Chen
authors.forename: Judy M
authors.initials: JM
authors.lastname: Simpson
authors.forename: Joan M
authors.initials: JM
authors.lastname: Lappe
authors.forename: Leif
authors.initials: L
authors.lastname: Mosekilde
authors.forename: Ross L
authors.initials: RL
authors.lastname: Prentice
authors.forename: Richard L
authors.initials: RL
authors.lastname: Prince
mesh_terms: D050071:Bone Density Conservation Agents / Q000009:adverse effects*; D002136:Calcium, Dietary / Q000627:therapeutic use*; D003327:Coronary Disease / Q000097:blood* / Q000401:mortality*; D019587:Dietary Supplements; D005260:Female; D006801:Humans; D017698:Postmenopause / Q000097:blood*
chemical_list: D050071:Bone Density Conservation Agents; D002136:Calcium, Dietary